[{"id":"fc6018ad-4547-4119-a893-d50b39ee1e4c","acronym":"","url":"https://clinicaltrials.gov/study/NCT00828984","created_at":"2021-01-18T03:09:18.427Z","updated_at":"2024-07-02T16:37:23.311Z","phase":"Phase 2","brief_title":"Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer","source_id_and_acronym":"NCT00828984","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" EGFR • CDH1 • CASP3 • SNAI1","pipe":" | ","alterations":" EGFR expression • CDH1 expression","tags":["EGFR • CDH1 • CASP3 • SNAI1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR expression • CDH1 expression"],"overall_status":"Completed","enrollment":" Enrollment 87","initiation":"Initiation: 10/01/2009","start_date":" 10/01/2009","primary_txt":" Primary completion: 10/01/2014","primary_completion_date":" 10/01/2014","study_txt":" Completion: 10/01/2014","study_completion_date":" 10/01/2014","last_update_posted":"2017-04-18"}]